Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

Affiliations

• ¹ Department of Nephrology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo, 108-0073, Japan.
• ² Department of Nephrology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo, 108-0073, Japan. [email protected].
• ³ Division of Nephrology, Shimoochiai Clinic, Tokyo, Japan.
• ⁴ Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, Japan.
• ⁵ Department of Hematology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
• ⁶ Department of Gastroenterology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.